13F-HR filed by Finepoint Capital LP
Finepoint Capital LP filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-14, with 26 holding rows worth $389,941,819.
- Accession
- 0000904454-24-000307
- Filer
- CIK 1608126
- Filed
- 2024-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 26 entries on the cover page, a total value of $389,941,819 stated on the cover page (in dollars after the unit check, H1), rows summing to $389,941,818 with VALUE read as dollars as filed, 13F file number 028-16580. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LIBERTY BROADBAND CORP | 530307305 | COM SER C | 1,886,260 | $107,950,660 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 592,528 | $29,164,228 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 175,672 | $26,556,336 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 539,100 | $22,254,048 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 677,100 | $21,822,933 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 158,457 | $20,513,843 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 50,000 | $19,686,000 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 360,916 | $18,128,811 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 238,046 | $16,689,405 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 503,759 | $16,221,040 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 840,453 | $15,539,976 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 656,600 | $13,571,922 | dollars as filed | |
| DISH NETWORK CORPORATION | 25470MAF6 | NOTE 12/1 | 18,300,000 | $13,450,500 | dollars as filed | principal |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 961,251 | $12,803,863 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 1,649,221 | $12,715,494 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 1,490,170 | $12,368,411 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 402,400 | $9,967,448 | dollars as filed | |
| CHURCHILL CAPITAL CORP VII | 17144M110 | *W EXP 02/29/202 | 548,000 | $175,360 | dollars as filed | |
| MONEYHERO LIMITED | G6202B119 | *W EXP 09/13/202 | 895,000 | $108,474 | dollars as filed | |
| FIRST LT ACQUISITION GROUP I | 320703101 | CL A | 125,000 | $70,625 | dollars as filed | |
| CONCORD ACQUISITION II CORP | 20607u116 | WT | 408,333 | $45,447 | dollars as filed | |
| COMPASS DIGITAL ACQUISITION CO | g2476c123 | WT | 459,906 | $42,311 | dollars as filed | |
| CALIDI BIOTHERAPEUTICS INC | 320703119 | *W EXP 03/14/202 | 655,200 | $34,070 | dollars as filed | |
| SWIFTMERGE ACQUISITION CORP | G63836111 | *W EXP 12/13/202 | 490,000 | $27,391 | dollars as filed | |
| SUMMIT HEALTHCARE ACQUISITION | g9845f117 | WT | 489,999 | $24,990 | dollars as filed | |
| MARBLEGATE ACQUISITION CORP | 56608A113 | *W EXP 08/31/202 | 735,000 | $8,232 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000904454-24-000307 | this filing | 2024-05-14 | acceptance time not in the bulk data set |